Votes & Verdicts cover art

Votes & Verdicts

Votes & Verdicts

By: Bloomberg
Listen for free

Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.

2026 Bloomberg
Economics Personal Finance Political Science Politics & Government
Episodes
  • Trump’s Cuba Plan and Business Implications
    Jun 26 2026

    What is the Trump administration’s approach to Cuba? How does it differ from President Donald Trump’s first term? And what happens next in the short term and the longer term? Ricardo Herrero, executive director of the Cuba Study Group, joins Bloomberg Intelligence’s Elliott Stein and Nathan Dean on this episode of the Votes and Verdicts podcast to discuss these and other related questions. Herrero also discusses the risks and opportunities for companies operating or seeking to operate in Cuba, and explores implications for banks like Santander and BBVA, for hotels like Melia and Iberostar and for crypto companies like Coinbase, among other sectors.

    See omnystudio.com/listener for privacy information.

    Show More Show Less
    49 mins
  • Bayer Roundup Suit’s SCOTUS Chances, Risks
    Jun 18 2026

    Bayer, facing tens of thousands of lawsuits over weedkiller Roundup, has set its sights on the Supreme Court. Dale Mullen, partner and co-chair of the business and corporate law section at Whiteford, joins Bloomberg Intelligence litigation analyst Holly Froum on this episode of the Votes and Verdicts podcast to discuss Bayer Monsanto’s appeal to the US Supreme Court of a $1.25 million verdict holding it liable for failing to warn that Roundup causes cancer. They discuss Bayer’s arguments, the company’s chance of success on appeal, risks that remain even if it secures a Supreme Court victory and more.

    See omnystudio.com/listener for privacy information.

    Show More Show Less
    30 mins
  • Marijuana Rescheduling in Washington
    Jun 12 2026

    What are the impacts of the Trump administration’s rescheduling of state-licensed medical cannabis to Schedule III from Schedule I? Could federal rescheduling extend to recreational marijuana later this year? If so, how should companies, firms and operators prepare for a world where significant tax relief and growth opportunities emerge? Would Congress face pressure to consider a federal tax on the budding sector if broader cannabis reform is in the cards? Foley Hoag Partner Jeffrey Schultz joins Bloomberg Intelligence’s Nathan Dean and Holly Froum on this episode of the Votes and Verdicts podcast to discuss these and other questions facing the industry.

    See omnystudio.com/listener for privacy information.

    Show More Show Less
    39 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet